Dr. Hung-I Yeh, is an adult cardiologist with basic research background. He graduated from Taipei Medical College in 1986, completed the training of internal medicine and cardiology in MacKay Memorial Hospital, Taipei, Taiwan in 1991, and got the PhD degree from National Heart and Lung Institute, Imperial College, United Kingdom in 1997. Afterwards he pursued a physician scientist career in MacKay Memorial Hospital and advocated translational research. He had been Director, Innovation and Incubation Center, Mackay Memorial Hospital (01/2008 – 12/2011). In 2009, he was assigned the founding chairperson of Department of Medicine, Mackay Medical College. He is also experienced in clinical research, been the Co-PI of more than 20 international large-scale clinical trials, such as those regarding novel pharmacotherapy in cardiometabolic, cardiovascular and cerebrovascular disease, for example, EMPA-REG OUTCOME, FOURIER, and ROCKET AF study. During the presidency of Taiwan Society of Lipids and Atherosclerosis (10/2015-09/2018), he led the revision of lipid management guidelines in Taiwan (J Formos Med Assoc. 2017;116:217-248), which lead to revision of the reimbursement regulations of National Health Insurance in Taiwan. Currently he is the Vice Superintendent of Mackay Memorial Hospital, the President of Taiwan Society of Geriatric Emergency and Critical Care Medicine, Honorary Director of Taiwan Society of Lipids and Atherosclerosis, and Director of Taiwan Society of Cardiology, as well as the Editor-in-chief of International Journal of Gerontology.